iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by SeaCrest Wealth Management LLC

SeaCrest Wealth Management LLC increased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 203.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,213 shares of the financial services provider’s stock after buying an additional 6,850 shares during the period. SeaCrest Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $1,487,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Blue Fin Capital Inc. boosted its position in shares of iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock worth $1,443,000 after buying an additional 74 shares in the last quarter. Security National Bank of SO Dak grew its position in shares of iShares Biotechnology ETF by 0.7% in the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares during the last quarter. Main Street Financial Solutions LLC increased its stake in shares of iShares Biotechnology ETF by 1.0% during the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock worth $1,098,000 after purchasing an additional 82 shares in the last quarter. Perkins Coie Trust Co raised its position in shares of iShares Biotechnology ETF by 0.3% during the 2nd quarter. Perkins Coie Trust Co now owns 25,184 shares of the financial services provider’s stock worth $3,457,000 after purchasing an additional 83 shares during the last quarter. Finally, HCR Wealth Advisors lifted its stake in iShares Biotechnology ETF by 0.6% in the 2nd quarter. HCR Wealth Advisors now owns 13,453 shares of the financial services provider’s stock valued at $1,847,000 after buying an additional 83 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

NASDAQ:IBB traded down $0.03 during trading hours on Wednesday, reaching $145.79. 62,985 shares of the company traded hands, compared to its average volume of 1,471,427. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.57. The firm’s 50-day moving average is $145.34 and its 200-day moving average is $139.50.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.